🥇 First rule of investing? Know when to save! Up to 55% off Investing Pro before BLACK FRIDAYCLAIM SALE

Rhoen Klinikum AG ADR (RKAGY)

OTC Markets
Currency in USD
6.0500
0.0000(0.00%)
Closed

RKAGY Income Statement

Advanced Income Statement
Period Ending:
2014
31/12
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa1,480.941,546.061,591.211,661.161,734.73
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+6.51%+4.4%+2.92%+4.4%+4.43%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa1,329.21,387.041,408.581,457.381,531.85
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa151.74159.02182.63203.78202.88
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-8.76%+4.8%+14.84%+11.58%-0.44%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa10.25%10.29%11.48%12.27%11.69%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa134.08151.7154.91172.47163.88
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa+6.35%+13.14%+2.12%+11.33%-4.98%
aa.aaaa.aaaa.aaaa.aaaa.aa-----
aa.aaaa.aaaa.aaaa.aaaa.aa4.23.823.84.34.8
aa.aaaa.aaaa.aaaa.aaaa.aa61.3678.2580.4798.6393.59
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa17.667.3327.7231.3139
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-56.1%-58.49%+278.21%+12.96%+24.55%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa1.19%0.47%1.74%1.88%2.25%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-2.8-6.6-2.7-2.86.8
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-59.27%-135.71%+59.09%-3.7%+342.86%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-3-7.4-3.2-4.1-3.7
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa0.20.80.51.310.5
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa2.21.131.292.122.23
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa17.051.8526.3130.6348.03
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa-0.1-1.03-0.1-0.2-0.3
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa37.33.31.73.2-
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa54.243.9327.3633.6347.73
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-14.14%-92.75%+595.85%+22.91%+41.93%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa3.66%0.25%1.72%2.02%2.75%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa9.761.47-2.876.697.56
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa44.482.4630.2326.9440.17
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa-1.2-1.01-1.93-1.8-1.46
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa43.281.4528.325.1438.71
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-11.67%-96.65%+1,850.03%-11.14%+53.96%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa2.92%0.09%1.78%1.51%2.23%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa43.281.4528.325.1438.71
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa0.650.020.420.380.58
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-11.67%-96.65%+1,850.1%-11.14%+53.96%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa0.650.020.420.380.58
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-11.44%-96.91%+2,000%-10.56%+53.96%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa66.9466.9466.9466.9466.94
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa66.9466.9466.9466.9466.94
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa---0.15-
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-----
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa82.9673.7394.8297.61101.5
EBITDA Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-16.73%-11.12%+28.6%+2.95%+3.98%
EBITDA Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa5.6%4.77%5.96%5.88%5.85%
EBIT
aa.aaaa.aa